The DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
Current status of selected oral peptide technologies in advanced preclinical development and in clinical trials
Open accessAbstract
The development of oral dosage forms that allows absorption of therapeutic peptides to the systemic circulation is one of the greatest challenges for the pharmaceutical industry. Currently, a number of technologies including either mixtures of penetration enhancers or protease inhibitors and/or nanotechnology-based products are under clinical development. Typically, these formulations are presented in the form of enteric-coated tablets or capsules. Systems undergoing preclinical investigation include further advances in nanotechnology, including intestinal microneedle patches, as well as their combination with regional delivery to the colon. This review critically examines four selected promising oral peptide technologies at preclinical stage and the twelve that have progressed to clinical trials, as indicated in www.clinicaltrials.gov. We examined these technologies under the criteria of peptide selection, formulation design, system components and excipients, intestinal mechanism of action, efficacy in man, and safety issues. The conclusion is that most of the technologies in clinical trials are incremental rather than paradigm-shifting and that even the more clinically advanced oral peptide drugs examples of oral bioavailability appear to yield oral bioavailability values of only 1-2% and are, therefore, only currently suitable for a limited range of peptides.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Peptide therapeutics: current status and future directions
Fosgerau, K., & Hoffmann, T. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2014.10.003 · Cited by 3,030
Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials
Gupta, S. C., Patchva, S., & Aggarwal, B. B. (2013) · The AAPS Journal · doi:10.1208/s12248-012-9432-8 · Cited by 2,110
Small-scale systems for in vivo drug delivery
LaVan, D. A., McGuire, T., & Langer, R. (2003) · Nature Biotechnology · doi:10.1038/nbt876 · Cited by 1,304
Contemporary strategies for peptide macrocyclization
White, C. J., & Yudin, A. K. (2011) · Nature Chemistry · doi:10.1038/nchem.1062 · Cited by 1,088
APD: the Antimicrobial Peptide Database
Wang, Z. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh025 · Cited by 808
Therapeutic potential of venom peptides
Lewis, R. J., & Garcia, M. L. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1197 · Cited by 798
Hauss, D. J. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.006 · Cited by 595
Colistin: an update on the antibiotic of the 21st century
Biswas, S., Brunel, J.-M., Dubus, J.-C., Reynaud-Gaubert, M., & Rolain, J.-M. (2012) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.12.78 · Cited by 581
Antimicrobial peptides stage a comeback
Fox, J. L. (2013) · Nature Biotechnology · doi:10.1038/nbt.2572 · Cited by 524
Desmopressin (DDAVP) in the Treatment of Bleeding Disorders: The First 20 Years
Mannucci, P. M. (1997) · Blood · doi:10.1182/blood.v90.7.2515 · Cited by 514
Macrocycles: lessons from the distant past, recent developments, and future directions
Yudin, A. K. (2015) · Chemical Science · doi:10.1039/c4sc03089c · Cited by 493
Intestinal Permeation Enhancers
Aungst, B. J. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/(sici)1520-6017(200004)89:4<429::aid-jps1>3.0.co;2-j · Cited by 489
Chey, W. D., Lembo, A. J., Lavins, B. J., Shiff, S. J., Kurtz, C. B., Currie, M. G., MacDougall, J. E., Jia, X. D., Shao, J. Z., Fitch, D. A., et al. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.254 · Cited by 463
The emergence of peptides in the pharmaceutical business: From exploration to exploitation
Uhlig, T., Kyprianou, T., Martinelli, F. G., Oppici, C. A., Heiligers, D., Hills, D., Calvo, X. R., & Verhaert, P. (2014) · EuPA Open Proteomics · doi:10.1016/j.euprot.2014.05.003 · Cited by 456
Bannunah, A. M., Vllasaliu, D., Lord, J., & Stolnik, S. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500439c · Cited by 421
Transepithelial Transport of Fc-Targeted Nanoparticles by the Neonatal Fc Receptor for Oral Delivery
Pridgen, E. M., Alexis, F., Kuo, T. T., Levy-Nissenbaum, E., Karnik, R., Blumberg, R. S., Langer, R., & Farokhzad, O. C. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3007049 · Cited by 405
STUDIES ON A BACTERICIDAL AGENT EXTRACTED FROM A SOIL BACILLUS
Dubos, R. J. (1939) · The Journal of Experimental Medicine · doi:10.1084/jem.70.1.1 · Cited by 358
Preparation and Characterization of Nanoparticles Shelled with Chitosan for Oral Insulin Delivery
Lin, Y.-H., Mi, F.-L., Chen, C.-T., Chang, W.-C., Peng, S.-F., Liang, H.-F., & Sung, H.-W. (2007) · Biomacromolecules · doi:10.1021/bm0607776 · Cited by 349
Oral delivery of macromolecular drugs: Where we are after almost 100 years of attempts
Moroz, E., Matoori, S., & Leroux, J.-C. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.01.010 · Cited by 336
Choonara, B. F., Choonara, Y. E., Kumar, P., Bijukumar, D., du Toit, L. C., & Pillay, V. (2014) · Biotechnology Advances · doi:10.1016/j.biotechadv.2014.07.006 · Cited by 311
Absorption Enhancers: Applications and Advances
Aungst, B. J. (2012) · The AAPS Journal · doi:10.1208/s12248-011-9307-4 · Cited by 309
In vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin delivery
Sonaje, K., Lin, Y.-H., Juang, J.-H., Wey, S.-P., Chen, C.-T., & Sung, H.-W. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2008.12.066 · Cited by 295
Kovarik, J. M., Mueller, E. A., Kutz, K., Van Bree, J. B., & Tetzloff, W. (1994) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600830336 · Cited by 294
Enzymatic barriers for GI peptide and protein delivery.
Woodley, J. F. (1994) · PubMed · Cited by 291
Sonaje, K., Chen, Y.-J., Chen, H.-L., Wey, S.-P., Juang, J.-H., Nguyen, H.-N., Hsu, C.-W., Lin, K.-J., & Sung, H.-W. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.01.042 · Cited by 281
Dunn, C. J., Wagstaff, A. J., Perry, C. M., Plosker, G. L., & Goa, K. L. (2001) · Drugs · doi:10.2165/00003495-200161130-00006 · Cited by 276
Improved Dose Linearity of Cyclosporine Pharmacokinetics from a Microemulsion Formulation
Mueller, E. A., Kovarik, J. M., van Bree, J. B., Tetzloff, W., Grevel, J., & Kutz, K. (1994) · Pharmaceutical Research · doi:10.1023/a:1018923912135 · Cited by 275
Oral protein delivery: Current status and future prospect
Park, K., Kwon, I. C., & Park, K. (2011) · Reactive and Functional Polymers · doi:10.1016/j.reactfunctpolym.2010.10.002 · Cited by 266
Wang, J., Yadav, V., Smart, A. L., Tajiri, S., & Basit, A. W. (2015) · Molecular Pharmaceutics · doi:10.1021/mp500809f · Cited by 245
Catry, B., Cavaleri, M., Baptiste, K., Grave, K., Grein, K., Holm, A., Jukes, H., Liebana, E., Navas, A. L., Mackay, D., et al. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.06.005 · Cited by 238
Busby, R. W., Bryant, A. P., Bartolini, W. P., Cordero, E. A., Hannig, G., Kessler, M. M., Mahajan-Miklos, S., Pierce, C. M., Solinga, R. M., Sun, L. J., et al. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.09.019 · Cited by 235
Pinto Reis, C., Neufeld, R. J., Ribeiro, A. J., & Veiga, F. (2006) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2006.04.009 · Cited by 215
Su, F.-Y., Lin, K.-J., Sonaje, K., Wey, S.-P., Yen, T.-C., Ho, Y.-C., Panda, N., Chuang, E.-Y., Maiti, B., & Sung, H.-W. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.12.038 · Cited by 206
Microneedles for Drug Delivery via the Gastrointestinal Tract
Traverso, G., Schoellhammer, C. M., Schroeder, A., Maa, R., Lauwers, G. Y., Polat, B. E., Anderson, D. G., Blankschtein, D., & Langer, R. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24182 · Cited by 202
Lin, Y.-H., Sonaje, K., Lin, K. M., Juang, J.-H., Mi, F.-L., Yang, H.-W., & Sung, H.-W. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.08.020 · Cited by 194
Sonaje, K., Lin, K.-J., Wey, S.-P., Lin, C.-K., Yeh, T.-H., Nguyen, H.-N., Hsu, C.-W., Yen, T.-C., Juang, J.-H., & Sung, H.-W. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.05.042 · Cited by 186
Halaby, T., al Naiemi, N., Kluytmans, J., van der Palen, J., & Vandenbroucke-Grauls, C. M. J. E. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02634-12 · Cited by 182
Improving drug biological effects by encapsulation into polymeric nanocapsules
Frank, L. A., Contri, R. V., Beck, R. C. R., Pohlmann, A. R., & Guterres, S. S. (2015) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1334 · Cited by 175
Safety and Efficacy of Oral Octreotide in Acromegaly: Results of a Multicenter Phase III Trial
Melmed, S., Popovic, V., Bidlingmaier, M., Mercado, M., van der Lely, A. J., Biermasz, N., Bolanowski, M., Coculescu, M., Schopohl, J., Racz, K., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-4113 · Cited by 173
Mueller, E. A., Kovarik, J. M., van Bree, J. B., Grevel, J., Lücker, P. W., & Kutz, K. (1994) · Pharmaceutical Research · doi:10.1023/a:1018922517162 · Cited by 170
Polymeric Nanoparticle Technologies for Oral Drug Delivery
Pridgen, E. M., Alexis, F., & Farokhzad, O. C. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.06.018 · Cited by 168
Krug, S. M., Amasheh, M., Dittmann, I., Christoffel, I., Fromm, M., & Amasheh, S. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.09.051 · Cited by 164
Tuvia, S., Atsmon, J., Teichman, S. L., Katz, S., Salama, P., Pelled, D., Landau, I., Karmeli, I., Bidlingmaier, M., Strasburger, C. J., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1179 · Cited by 160
Oral Insulin and Buccal Insulin: A Critical Reappraisal
Heinemann, L., & Jacques, Y. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300323 · Cited by 154
Significance of microflora in proteolysis in the colon
Gibson, S. A., McFarlan, C., Hay, S., & Macfarlane, G. T. (1989) · Applied and Environmental Microbiology · doi:10.1128/aem.55.3.679-683.1989 · Cited by 150
Binkley, N., Bolognese, M., Sidorowicz-Bialynicka, A., Vally, T., Trout, R., Miller, C., Buben, C. E., Gilligan, J. P., Krause, D. S., & for the Oral Calcitonin in Postmenopausal Osteoporosis (ORACAL) Investigators (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1602 · Cited by 149
Zaoral, M., Kolc, J., & Šorm, F. (1967) · Collection of Czechoslovak Chemical Communications · doi:10.1135/cccc19671250 · Cited by 144
Karsdal, M. A., Byrjalsen, I., Alexandersen, P., Bihlet, A., Andersen, J. R., Riis, B. J., Bay-Jensen, A. C., & Christiansen, C. (2015) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2014.12.019 · Cited by 143
Tuvia, S., Pelled, D., Marom, K., Salama, P., Levin-Arama, M., Karmeli, I., Idelson, G. H., Landau, I., & Mamluk, R. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1303-9 · Cited by 142
Curcumin–glutathione interactions and the role of human glutathione S-transferase P1-1
Awasthi, S., Pandya, U., Singhal, S. S., Lin, J. T., Thiviyanathan, V., Seifert, W. E., Awasthi, S., & Ansari, G. A. S. (2000) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(00)00185-x · Cited by 128
Oral colon delivery of insulin with the aid of functional adjuvants
Maroni, A., Zema, L., Curto, M. D. D., Foppoli, A., & Gazzaniga, A. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.10.006 · Cited by 127
Reversible lipidization for the oral delivery of salmon calcitonin
Wang, J., Chow, D. D., Heiati, H., & Shen, W. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00008-7 · Cited by 125
Nguyen, H.-N., Wey, S., Juang, J.-H., Sonaje, K., Ho, Y., Chuang, E., Hsu, C.-W., Yen, T., Lin, K., & Sung, H. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2010.12.044 · Cited by 117
Larsen, A. T., Holm, R., Pedersen, M. L., & Müllertz, A. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9641-0 · Cited by 106
Overcoming poor permeability: translating permeation enhancers for oral peptide delivery
Maher, S., & Brayden, D. J. (2011) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2011.11.006 · Cited by 103
Self-citationRubinstein, A., Tirosh, B., Baluom, M., Nassar, T., David, A., Radai, R., Gliko-Kabir, I., & Friedman, M. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(96)01582-9 · Cited by 100
Karsdal, M. A., Byrjalsen, I., Henriksen, K., Riis, B. J., Lau, E. M. C., Arnold, M., & Christiansen, C. (2009) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2009.08.004 · Cited by 98
Shailubhai, K., Comiskey, S., Foss, J. A., Feng, R., Barrow, L., Comer, G. M., & Jacob, G. S. (2013) · Digestive Diseases and Sciences · doi:10.1007/s10620-013-2684-z · Cited by 98
Eldor, R., Arbit, E., Corcos, A., & Kidron, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059524 · Cited by 94
Hepatic-Directed Vesicle Insulin: A Review of Formulation Development and Preclinical Evaluation
Geho, W. B., Geho, H. C., Lau, J. R., & Gana, T. J. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300627 · Cited by 92
Challenges in the Delivery of Peptide drugs: an Industry Perspective
Lewis, A. L., & Richard, J. (2015) · Therapeutic Delivery · doi:10.4155/tde.14.111 · Cited by 88
Walsh, E. G., Adamczyk, B. E., Chalasani, K. B., Maher, S., O‘Toole, E. B., Fox, J. S., Leonard, T. W., & Brayden, D. J. (2011) · Therapeutic Delivery · doi:10.4155/tde.11.132 · Cited by 86
Self-citationWelling, S. H., Hubálek, F., Jacobsen, J. B., Brayden, D. J., Rahbek, U. L., & Buckley, S. T. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.12.017 · Cited by 86
Self-citationRyan, S. M., Wang, X., Mantovani, G., Sayers, C. T., Haddleton, D. M., & Brayden, D. J. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.12.014 · Cited by 84
Self-citationRitschel, W. A. (1996) · Clinical Transplantation · doi:10.1111/j.1399-0012.1996.tb00458.x · Cited by 79
Formulation and Evaluation of a Folic Acid Receptor-Targeted Oral Vancomycin Liposomal Dosage Form
Anderson, K. E., Eliot, L., Stevenson, B. R., & Rogers, J. A. (2001) · Pharmaceutical Research · doi:10.1023/a:1011002913601 · Cited by 79
Zijlstra, E., Heinemann, L., & Plum‐Mörschel, L. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814529988 · Cited by 73
Shailubhai, K. (2015) · World Journal of Gastrointestinal Pharmacology and Therapeutics · doi:10.4292/wjgpt.v6.i4.213 · Cited by 73
Does salmon calcitonin cause cancer? A review and meta-analysis
Wells, G. A., Chernoff, J., Gilligan, J. P., & Krause, D. S. (2015) · Osteoporosis International · doi:10.1007/s00198-015-3339-z · Cited by 71
Luzio, S. D., Dunseath, G. J., Lockett, A., Broke-Smith, T. P., New, R. R. C., & Owens, D. R. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01146.x · Cited by 71
Houben, A. J. M., Oostdijk, E. A. N., van der Voort, P. H. J., Monen, J., Bonten, M. J. M., van der Bij, A. K., on behalf of the ISIS-AR Study Group, Vlaspolder, F., Stuart, J. W. T. C., van Hees, B. C., et al. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt416 · Cited by 71
Formulation Strategies to Improve Oral Peptide Delivery
Maher, S., Ryan, B. K., Duffy, A. M., & Brayden, D. J. (2014) · Pharmaceutical Patent Analyst · doi:10.4155/ppa.14.15 · Cited by 70
Self-citationKhedkar, A., Iyer, H., Anand, A. C., Verma, M., Krishnamurthy, S., Savale, S. S., & Atignal, A. (2010) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01213.x · Cited by 69
Lessons learned from the clinical development of oral peptides
Karsdal, M. A., Riis, B. J., Mehta, N., Stern, W., Arbit, E., Christiansen, C., & Henriksen, K. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12557 · Cited by 66
II. Needle phobia: a psychological perspective
Jenkins, K. (2014) · British Journal of Anaesthesia · doi:10.1093/bja/aeu013 · Cited by 66
Opioid peptides: potential for drug development
Aldrich, J. V., & McLaughlin, J. P. (2011) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2011.07.007 · Cited by 65
Petersen, S. B., Nolan, G., Maher, S., Rahbek, U. L., Guldbrandt, M., & Brayden, D. J. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.08.010 · Cited by 62
Self-citationRubinstein, A. (2005) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2005.05.021 · Cited by 58
Castelli, M., Wong, D. F., Friedman, K., & Riley, M. G. I. (2011) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.05.088 · Cited by 54
Wang, X., Maher, S., & Brayden, D. J. (2010) · Therapeutic Delivery · doi:10.4155/tde.10.5 · Cited by 53
Self-citationHenriksen, K., Andersen, J. R., Riis, B. J., Mehta, N., Tavakkol, R., Alexandersen, P., Byrjalsen, I., Valter, I., Nedergaard, B. S., Teglbjærg, C. S., et al. (2012) · Bone · doi:10.1016/j.bone.2012.11.045 · Cited by 53
Chuang, E., Nguyen, G. T. H., Su, F.-Y., Lin, K., Chen, C.-T., Mi, F., Yen, T., Juang, J.-H., & Sung, H. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.07.021 · Cited by 52
Why Most Oral Insulin Formulations do Not Reach Clinical Trials
Lopes, M., Simões, S. M. N., Veiga, F., Seiça, R. M. F., & Ribeiro, A. J. (2015) · Therapeutic Delivery · doi:10.4155/tde.15.47 · Cited by 49
Alam, Z. A., Wu, X., Mascio, C. T. M., Chesnel, L., & Hurdle, J. G. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01087-15 · Cited by 45
Maher, S., Wang, X., Bzik, V. A., McClean, S., & Brayden, D. J. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.07.011 · Cited by 43
Self-citationSolution Structure of the Osteogenic 1−31 Fragment of the Human Parathyroid Hormone
Chen, Z., Xu, P., Barbier, J.-R., Willick, G. E., & Ni, F. (2000) · Biochemistry · doi:10.1021/bi000882e · Cited by 42
Weinberg, R. S., Grecco, M. O., Ferro, G. S., Seigelshifer, D. J., Perroni, N. V., Terrier, F., Sánchez‐Luceros, A., Maronna, E., Sánchez-Marull, R., Frahm, I., et al. (2015) · SpringerPlus · doi:10.1186/s40064-015-1217-y · Cited by 41
Geho, W. B., Rosenberg, L. N., Schwartz, S. L., Lau, J. R., & Gana, T. J. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814524871 · Cited by 41
Reid, P. F. (2007) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v27.i4.10 · Cited by 40
Binkley, N., Bone, H. G., Gilligan, J. P., & Krause, D. S. (2014) · Osteoporosis International · doi:10.1007/s00198-014-2796-0 · Cited by 38
Eldor, R., Kidron, M., & Arbit, E. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01153.x · Cited by 37
Keohane, K., Rosa, M., Coulter, I. S., & Griffin, B. T. (2015) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2015.1044905 · Cited by 36
Self-citationVisca, A., Bishop, C. T., Hilton, S. C., & Hudson, V. M. (2008) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2008.03.006 · Cited by 36
Hanefeld, M., Monnier, L., Schnell, O., & Owens, D. R. (2016) · Diabetes Therapy · doi:10.1007/s13300-016-0153-3 · Cited by 36
Maggio, E., & Grasso, P. (2011) · Regulatory Peptides · doi:10.1016/j.regpep.2011.02.009 · Cited by 35
Miner, P. B., DeLuca, R., Portilla, M. D. L., Padila, E., Koltun, W. D., Wiltz, O., Shailubhai, K., Jacob, G., Griffin, P. H., & Barrow, L. (2014) · The American Journal of Gastroenterology · doi:10.14309/00000434-201410002-01831 · Cited by 34
Miner, P. B., Surowitz, R., Fogel, R., Koltun, W. D., Drossman, D. A., Camilleri, M., Mangel, A. W., Barrow, L., Jacob, G. S., & Shailubhai, K. (2013) · Gastroenterology · doi:10.1016/s0016-5085(13)60585-5 · Cited by 32
Stauss‐Grabo, M., Atiye, S., Le, T. H. M., & Kretschmar, M. (2014) · Die Pharmazie · doi:10.31083/ph.2014.4686 · Cited by 31
Peptide Therapeutics: it‘s All in the Delivery
GRANT, M. L., & Leone‐Bay, A. (2012) · Therapeutic Delivery · doi:10.4155/tde.12.79 · Cited by 30
Oral Reduced L‐Glutathione Improves Growth in Pediatric Cystic Fibrosis Patients
Visca, A., Bishop, C. T., Hilton, S. C., & Hudson, V. M. (2015) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000000738 · Cited by 27
Aguirre, T. A. S., Rosa, M., Coulter, I. S., & Brayden, D. J. (2015) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2015.09.001 · Cited by 26
Self-citationMarshall, P. A., Jurutka, P. W., Wagner, C. E., van der Vaart, A., Kaneko, I., Chavez, P. I., Ma, N., Bhogal, J. S., Shahani, P. H., Swierski, J. C., et al. (2015) · Pharmacology Research & Perspectives · doi:10.1002/prp2.122 · Cited by 26
Kelly, J., Boyle, N. T., Cole, N., Slator, G. R., Colivicchi, M. A., Stefanini, C., Gobbo, O. L., Scalabrino, G., Ryan, S. M., Elamin, M., et al. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.09.024 · Cited by 23
Self-citationLeinung, M. C., & Grasso, P. (2012) · Regulatory Peptides · doi:10.1016/j.regpep.2012.08.006 · Cited by 22
Kang, S. B., Marchelletta, R. R., Penrose, H. M., Docherty, M. J., & McCole, D. F. (2015) · Pharmacology Research & Perspectives · doi:10.1002/prp2.128 · Cited by 8
(2008) · Wiley eBooks · doi:10.1002/9780471462422.eoct505 · Cited by 4
Novel Formulations for Non-Invasive Delivery and Stabilization of Peptides
Maggio, E. (2013) · American Peptide Symposium (APS) · doi:10.17952/23aps.2013.030 · Cited by 2
Dual-region in vivo Functional Imaging with a Spatial Light Modulator
Yang, W., Miller, J.-E. K., Carrillo‐Reid, L., Yuste, R., & Peterka, D. S. (2015) · Optics in the Life Sciences · doi:10.1364/boda.2015.brw3b.2 · Cited by 1
Cited by
The Current State of Peptide Drug Discovery: Back to the Future?
Henninot, A., Collins, J. C., & Nuss, J. M. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00318 · Cited by 1,113
Non-invasive delivery strategies for biologics
Anselmo, A. C., Gokarn, Y., & Mitragotri, S. (2019) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.183 · Cited by 665
Advances in oral peptide therapeutics
Drucker, D. J. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0053-0 · Cited by 646
Transcellular Stomach Absorption of a Derivatized Glucagon-Like Peptide-1 Receptor Agonist
Buckley, S. T., Bækdal, T. A., Vegge, A., Maarbjerg, S. J., Pyke, C., Ahnfelt-Rønne, J., Madsen, K. G., Schéele, S. G., Alanentalo, T., Kirk, R. K., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aar7047 · Cited by 553
An ingestible self-orienting system for oral delivery of macromolecules
Abramson, A., Caffarel-Salvador, E., Khang, M., Dellal, D., Silverstein, D., Gao, Y., Frederiksen, M. R., Vegge, A., Hubálek, F., Water, J. J., et al. (2019) · Science · doi:10.1126/science.aau2277 · Cited by 452
Metadata
- Authors
- Aguirre, T. A. S., Teijeiro-Osorio, D., Rosa, M., Coulter, I. S., Alonso, M. J., & Brayden, D. J.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2016-11
- Volume
- 106
- Issue
- Pt B
- Pages
- 223-241
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2284082872
- Cited by
- 299
- References
- 108
- FWCI
- 2.27
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.